decabromobiphenyl ether has been researched along with Diabetes Mellitus, Type 2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Dong, F; Feng, W; Liao, T; Mao, G; Shi, X; Tang, J; Wu, X; Yang, L; Zhao, T | 1 |
1 other study(ies) available for decabromobiphenyl ether and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Metabolism toxicity and susceptibility of decabromodiphenyl ether (BDE-209) exposure on BRL cells with insulin resistance.
Topics: Animals; Cell Line; Diabetes Mellitus, Type 2; Glucose; Glycogen Synthase Kinase 3 beta; Halogenated Diphenyl Ethers; Insulin Resistance; Phosphatidylinositol 3-Kinases | 2022 |